M V Borobio

511 total citations
24 papers, 407 citations indexed

About

M V Borobio is a scholar working on Pharmacology, Parasitology and Clinical Biochemistry. According to data from OpenAlex, M V Borobio has authored 24 papers receiving a total of 407 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 7 papers in Parasitology and 5 papers in Clinical Biochemistry. Recurrent topics in M V Borobio's work include Antibiotics Pharmacokinetics and Efficacy (8 papers), Antibiotic Resistance in Bacteria (5 papers) and Syphilis Diagnosis and Treatment (5 papers). M V Borobio is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (8 papers), Antibiotic Resistance in Bacteria (5 papers) and Syphilis Diagnosis and Treatment (5 papers). M V Borobio collaborates with scholars based in Spain, Sweden and Denmark. M V Borobio's co-authors include Evelio J. Perea, Miguel A. Muniain, Álvaro Pascual, Javier Aznar, Edward Guy, Oliver Liesenfeld, Valeria Meroni, Anne Naessens, P. Thulliez and Eskild Petersen and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

M V Borobio

22 papers receiving 358 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M V Borobio Spain 11 167 123 114 88 78 24 407
David V. Alcid United States 10 53 0.3× 130 1.1× 108 0.9× 96 1.1× 70 0.9× 17 377
Lih-Shinn Wang Taiwan 13 59 0.4× 149 1.2× 102 0.9× 55 0.6× 187 2.4× 35 478
L L Van Etta United States 10 188 1.1× 199 1.6× 61 0.5× 127 1.4× 62 0.8× 13 417
Sabine Schmoldt Germany 11 40 0.2× 138 1.1× 159 1.4× 47 0.5× 180 2.3× 13 534
Frédéric Schramm France 10 97 0.6× 186 1.5× 91 0.8× 20 0.2× 40 0.5× 33 421
Richard F. Trotta United States 5 135 0.8× 201 1.6× 80 0.7× 62 0.7× 19 0.2× 6 402
Isobel Rutherford United States 13 212 1.3× 112 0.9× 111 1.0× 47 0.5× 44 0.6× 20 572
Neville Mobarakai United States 10 84 0.5× 228 1.9× 83 0.7× 45 0.5× 38 0.5× 43 399
F Soriano Spain 11 39 0.2× 116 0.9× 167 1.5× 48 0.5× 39 0.5× 30 347
S. Hunt Gerardo United States 13 13 0.1× 107 0.9× 88 0.8× 60 0.7× 63 0.8× 23 457

Countries citing papers authored by M V Borobio

Since Specialization
Citations

This map shows the geographic impact of M V Borobio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M V Borobio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M V Borobio more than expected).

Fields of papers citing papers by M V Borobio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M V Borobio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M V Borobio. The network helps show where M V Borobio may publish in the future.

Co-authorship network of co-authors of M V Borobio

This figure shows the co-authorship network connecting the top 25 collaborators of M V Borobio. A scholar is included among the top collaborators of M V Borobio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M V Borobio. M V Borobio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rodríguez‐Baño, Jesús, et al.. (2004). Cytomegalovirus mononucleosis as a cause of prolonged fever and prominent weight loss in immunocompetent adults. Clinical Microbiology and Infection. 10(5). 468–470. 8 indexed citations
2.
Borobio, M V. (2003). Presente y futuro de la serología. Enfermedades Infecciosas y Microbiología Clínica. 21(Supl.2). 84–89. 1 indexed citations
3.
Muniain, Miguel A., et al.. (1998). Genotypic identification of an undescribed spotted fever group rickettsia in Ixodes ricinus from southwestern Spain.. American Journal of Tropical Medicine and Hygiene. 58(5). 570–577. 58 indexed citations
4.
Borobio, M V, Ana Isabel Suárez, Encarnación Ramírez, & Evelio J. Perea. (1997). Evaluation of in vitro activity of a new fluoroquinolone trovafloxacin (cp-99,219) compared with other anti-anaerobic antimicrobials against members of the Bacteroides fragilis group. International Journal of Antimicrobial Agents. 8(4). 249–252. 1 indexed citations
5.
Carrascosa, Miguel F., et al.. (1997). Rhabdomyolysis Associated with Acute Q Fever. Clinical Infectious Diseases. 25(5). 1243–1244. 10 indexed citations
6.
García-Moreno, J M, et al.. (1997). [Neuroborreliosis in a patient with progressive supranuclear paralysis. An association or the cause?].. PubMed. 25(148). 1919–21. 6 indexed citations
7.
Borobio, M V, Álvaro Pascual, Ana Isabel Suárez, et al.. (1996). Evolution of the antimicrobial susceptibility of B. fragilis group at the university hospital of Seville (Spain) between 1977 and 1995. International Journal of Antimicrobial Agents. 7(1). 1–7. 2 indexed citations
8.
Borobio, M V, M. Carmen Conejo, Encarnación Ramírez, Ana Isabel Suárez, & Evelio J. Perea. (1994). Comparative activities of eight quinolones against members of the Bacteroides fragilis group. Antimicrobial Agents and Chemotherapy. 38(6). 1442–1445. 13 indexed citations
9.
Bullón, Pedro, et al.. (1993). Late onset Papillon‐Lefévre syndrome?. Journal Of Clinical Periodontology. 20(9). 662–667. 51 indexed citations
10.
Rodríguez‐Pichardo, Antonio, Javier Aznar, Francisco Camacho, M V Borobio, & Evelio J. Perea. (1991). Sexually transmitted diseases in homosexual males in Seville, Spain.. Sexually Transmitted Infections. 67(4). 335–338. 8 indexed citations
11.
Borobio, M V, et al.. (1989). [Prevalence of antibodies against Borrelia burgdorferi among the population of Seville].. PubMed. 7(9). 489–90. 2 indexed citations
12.
Borobio, M V. (1987). Current problems in syphilis serology. Serodiagnosis and Immunotherapy in Infectious Disease. 1(6). 393–397.
13.
Borobio, M V, et al.. (1986). Effect of medium, pH, and inoculum size on activity of ceftizoxime and Sch-34343 against anaerobic bacteria. Antimicrobial Agents and Chemotherapy. 30(4). 626–627. 17 indexed citations
14.
Borobio, M V, et al.. (1985). Evaluation of a solid-phase enzyme immunoassay in the diagnosis of syphilis. RUA, Repositorio Institucional de la Universidad de Alicante (Universidad de Alicante). 6 indexed citations
15.
Borobio, M V & Evelio J. Perea. (1984). Effect of inoculum, pH, and medium on the activity of ciprofloxacin against anaerobic bacteria. Antimicrobial Agents and Chemotherapy. 25(3). 342–343. 24 indexed citations
16.
Perea, Evelio J., et al.. (1981). Three years' experience of sexually transmitted diseases in Seville, Spain.. Sexually Transmitted Infections. 57(3). 174–177. 3 indexed citations
17.
Borobio, M V, et al.. (1981). N-formimidoyl-thienamycin activity against anaerobes: effect of the inoculum, pH and culture media. Journal of Antimicrobial Chemotherapy. 8(3). 213–218. 7 indexed citations
18.
Borobio, M V, et al.. (1980). Value of serological diagnosis in congenital syphilis. Report of nine cases.. Sexually Transmitted Infections. 56(6). 377–380. 4 indexed citations
19.
Borobio, M V, et al.. (1980). Comparative in vitro activity of 1-oxa-beta-lactam (LY127935) and cefoperazone with other beta-lactam antibiotics against anaerobic bacteria. Antimicrobial Agents and Chemotherapy. 17(2). 129–131. 45 indexed citations
20.
Perea, Evelio J., et al.. (1978). Cefoxitin sodium activity against anaerobes: effect of the inoculum size, pH variation and different culture media. Journal of Antimicrobial Chemotherapy. 4(suppl B). 55–60. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026